Metro Healthcare Indonesia Tbk. vs Diastika Biotekindo Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp426 (market cap 14.23T, 106.3K 24h volume), while Diastika Biotekindo Tbk. trades at Rp132 (market cap 534.73B, 418.3K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is far larger — about 26.6× Diastika Biotekindo Tbk.'s market cap, and Diastika Biotekindo Tbk. is more actively traded (418.3K versus 106.3K). Which is the better fit depends on your goals.
| CARE | CHEK | |
|---|---|---|
Market Cap | 14.23T | 534.73B |
Volume | 106.3K | 418.3K |
Lot | 1.06K | 4.18K |
Turnover | 45.42M | 54.5M |
Average Price | 427.26 | 130.28 |
Value | 45.42M | 54.5M |
Indicative Equilibrium Price | 426 | 132 |
Indicative Equilibrium Volume | 25 | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →